Machine Learning
Unsupervised clustering and random forest applied to genotype-to-phenotype inverse design, plus local LLM/RAG tooling for translating published literature into actionable features and algorithms.
Currently applying this at Meso Scale Discovery: clustering antibody-screening data to create new process features, with an R Shiny app for epitope mapping and cross-sample consensus.